Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Glycaemic Control of Type 2 Diabetic Patients on Follow Up at Hospital Universiti Sains Malaysia

Eid, M. and Mafauzy Mohamed, and Faridah, A.R. (2003) Glycaemic Control of Type 2 Diabetic Patients on Follow Up at Hospital Universiti Sains Malaysia. Malaysian Journal of Medical Sciences, 10 (2). pp. 40-49. ISSN 1394195X

Full text not available from this repository.

Official URL: http://www.medic.usm.my/publication/mjms/

Affiliations

Universiti Sains Malaysia, School of Medical Sciences, Dept. of Chemical Pathology
Universiti Sains Malaysia, School of Medical Sciences, Dept. of Medicine

Abstract

Two hundred and eleven (211) patients with type 2 diabetes mellitus who were on treatment and monitored for complications at the Outpatient Diabetes Clinic in Hospital Universiti Sains Malaysia, Kubang Kerian between 2001 – 2002 were selected for the study. A structured questionnaire was administered to obtain their medical and family history. Physical examination was performed and fasting venous blood sample was collected for plasma glucose and A1C analysis. Of the total 211 patients, only 4 % were on diet treatment alone, 37% of them were on mono
therapy while 59 % were on combination of therapies. Fasting plasma glucose (FPG) > 7.2 mmol/L and glycated hemoglobin (A1C) levels ³ 7% were observed in 60 % and 73 % of type 2 diabetic patients, respectively. Glycated hemoglobin level of 28% of the subjects were < 7%; 36% were between 7 – 9% and 36% were more than 9%. The worst glycaemic control was observed in Malay patients. A1C of Malay and non-Malay subjects were 8.7 ± 2.3 % and 7.7 ± 1.7 %, respectively. Younger patients (age group < 50 years) had significantly higher mean A1C than elderly patients. Duration of diabetes had a clear influence on glycaemic level. Patients with recently diagnosed diabetes (duration of disease < 5 years) had the best glycaemic control. In this study a large proportion of the patients had poor glycaemic control. The variables with significant effects on glycaemic control were ethnicity, age and duration of diabetes mellitus. Better treatment strategies
and methods should be used to improve diabetes control and to reduce long-term complications of diabetes.

Item Type:Journal
Keywords:Glycaemic Control, Type 2 Diabetes Mellitus
Subjects:R Medicine
ID Code:898

1. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch, W., Smith S.C., & Sowers J.R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134 – 1146.

2. Mafauzy M., Mokhtar N., Wan Muhamad W.B., & Musalmah M. Diabetes mellitus and associated cardiovascular risk factors in North-East Malaysia. Asian-Pacific J Public Health 1999; 11 (1): 16 – 19.

3. Public Health Institute, Ministry of Health Malaysia. Report of the Second National Health and Morbidity Survey Conference 1997: 81 – 89.

4. Bloomgarden Z.T. International Diabetes Federation meeting (type 2 diabetes: its prevalence, causes, and treatment). Diabetes Care 1998; 21 (5): 860 – 865.

5. Kuusisto J., Mykkanen L., Pyorala K., & Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43:960 – 967.

6. Van der Does F.E.E., Neeling J.N.D., Snoek F.J., Grootenhuis P.A., Kostense P.J., Bouter L.M., & Heine R.J. Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes (Effects on well-being at 1 year). Diabetes Care 1998; 21 (12): 2085 – 2093.

7. Herman W.H. Glycaemic control in diabetes. BMJ 1999; 319: 104 – 106.

8. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993; 329(14): 977 – 986.

9. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS33). Lancet 1998; 352: 837 – 853.

10. Bunn H.F. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 1981; 70: 325 – 330.

11. Jovanovic L. & Peterson C.M. The clinical utility glycosylated hemoglobin. Am J Med 1981; 70: 331 338.

12. Nathan D.M, Singer D.E., Hurxthal K., & Goodson The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984; 310 (6): 341-346.

13. Cefalu W.T., Wang Z.Q., Bell-Farrow A., Kiger F.D., Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 1994;(7):1317 – 1321.

14. Goldstein D.E., Little R.R., Lorenz R.A., Malone Nathan D., & Peterson C.M. Tests of glycemia diabetes. Diabetes Care 1995; 18 (6): 896 – 909.

15. American Diabetes Association. Standards of Medical Care for Patients With Diabetes Mellitus (Position Statement). Diabetes Care 2002; 25 (1): 213 – 229.

16. Mohamad M., Arshad F., Mohd Noor M.I., & Ali R. Prevalence of dyslipidaemia in non-insulin-dependent diabetic patients attending armed forces clinics in Kuala Lumpur. Asia Pacific J Clin Nutr 1997; 6 (3):203 – 206.

17. Valle T., Koivisto V.A., Reunanen A., Kangas T., & Rissanen, A. Glycemic control in patients with diabetes in Finland. Diabetes Care 1999; 22 (4): 575 – 579.

18. Miller C.D., Phillips L.S., Tate M.K., Porwoll J.M., Rossman S.D., Cronmiller N., & Gebhart S.S.P. Meeting American Diabetes Association Guidelines in Endocrinologist Practice. Diabetes Care 2000; 23 (4):444 – 448.

19. Ismail I.S., Nazaimoon W., Muhamad W., Letchuman R.,

Singaraveloo M., Hew F.L., Shuguna C., & Khalid B.A.K. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia. Diabetic Medicine 2001; 18: 501 – 508.

20. Östgren C.J., Lindblad U., Ranstam J., Melander A, & Råstam L. Glycaemic control, disease duration and b cell function in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project. Diabetic Medicine 2002; 19: 125 –129.

Repository Staff Only: item control page
 
 
 
 
 
   
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.